Panacea Biotec - About the company
Panacea Biotec is a public company based in Ambala (India), founded in 1984 by Soshil Kumar Jain. It operates as a Developer of biosimilars, vaccines and natural products. Panacea Biotec has raised an undisclosed amount in funding.
Company Details
Panacea Biotec involved in research, manufacturing and marketing of branded pharmaceutical formulations, vaccines, biosimilars (antibodies, proteins) and natural products. The product portfolio includes prescription products in therapeutic areas like pain management, diabetes, cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines.
- Website
- www.panaceabiotec.com
- Email ID
- *****@panaceabiotec.com
- Registered Address
- 1584/6 M V BUILDING 1ST FLOORCHANDNI CHOWK DELHI 110006, NA, Delhi, India, 000000
Key Metrics
Founded Year
1984
Location
Ambala, India
Stage
Public
Latest Funding Round
Investors
Annual Revenue
₹500 - ₹1,000 Cr as on Mar 31, 2026
Employee Count
3,090 as on Oct 31, 2026
Exit Details
Public
Legal entities associated with Panacea Biotec
Panacea Biotec is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
PANACEA BIOTEC PHARMA LIMITED CIN: U24299PB2019PLC068319 , India, Active | Mar 22, 2019 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 830 (As on Oct 31, 2024) | |
PANACEA BIOTEC LIMITED CIN: U24233DL1984PLC017475 , India, Inactive for e-filing | Feb 02, 1984 | ₹500 - ₹1,000 Cr (As on Mar 31, 2026) | 1522 (As on Aug 31, 2025) |
Panacea Biotec's IPO details
Panacea Biotec got listed on Apr 17, 1996.
Click here to take a look at Panacea Biotec's IPO in detail
Sign up to download Panacea Biotec's company profile
Panacea Biotec's funding and investors
Panacea Biotec has raised funding over 3 rounds. Its latest funding round was a Post IPO round on Apr 2019 for $*****. 1 investor participated in its latest round. Panacea Biotec has 3 institutional investors.
Here is the list of recent funding rounds of Panacea Biotec:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 2019 | 3445035 | Post IPO | 5572162 | 2436255 | 4364324 | 1769099 |
Sep 2011 | 2424924 | Conventional Debt | 3677267 | 8681712 | 3600243 | 2496971 |
View details of Panacea Biotec's funding rounds and investors
Panacea Biotec's founders and board of directors
Founder? Claim ProfileThe founders of Panacea Biotec is Soshil Kumar Jain.
Here are the details of Panacea Biotec's key team members:
- Soshil Kumar Jain: Former Founder of Panacea Biotec.
View details of Panacea Biotec's Founder profiles and Board Members
Panacea Biotec's employee count trend
Panacea Biotec has 3,090 employees as of Oct 26. Here is Panacea Biotec's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Financials of Panacea Biotec
PANACEA BIOTEC LIMITED, the legal entity associated with Panacea Biotec, generated between ₹500 Cr and ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2024. The revenue of PANACEA BIOTEC LIMITED has a compounded annual growth rate (CAGR) of 14% in the last 1 year.
Financial Statement Summary
Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5123 | 7489 | 9492 | 8917 | 8358 |
Total Sales | 8283 | 6102 | 9885 | 5788 | 2978 |
Total Expenses | 7782 | 7954 | 7407 | 4440 | 5300 |
Operating Expenses | 7455 | 2151 | 5563 | 7780 | 6514 |
Expenses from other activities | 4512 | 1711 | 1800 | 8120 | 3562 |
EBITDA | 2143 | 8299 | 1261 | 1919 | 1170 |
Taxes | 5324 | 3329 | 9970 | 4564 | 5729 |
Balance Sheet | |||||
Assets | 2341 | 2549 | 6134 | 5452 | 7002 |
Inventory | 6696 | 8134 | 3110 | 7618 | 4292 |
Liabilities | 6320 | 9501 | 4980 | 5655 | 5763 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Panacea Biotec's Investments and acquisitions
Panacea Biotec has made no investments or acquisitions yet.
Reports related to Panacea Biotec
Here is the latest report on Panacea Biotec's sector:
News related to Panacea Biotec
Media has covered Panacea Biotec for 1 event in last 1 year.
•
Panacea Biotec Faces Rs 9.82 Crore Income Tax Penalty Demand for Alleged Income MisreportingMedical Dialogues•Sep 29, 2026•Panacea Biotec
•
•
ICMR: Phase-3 trial enrolment for India’s first dengue vaccine to be completed by OctoberJourney Line•Jul 14, 2025•Panacea Biotec, ICMR
•
Panacea Biotec shares in focus on contract from UNICEFMoneycontrol•Dec 26, 2024•UNICEF, Panacea Biotec
•
Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highIndiatimes•Sep 17, 2024•Panacea Biotec, Sanofi
•
USDFC extends $50 mn debt funding to Vastu Housing FinanceVCCircle•Sep 12, 2024•Vastu Housing Finance, DFC, Panacea Biotec
•
Orient Electric onboards Sanjeev Bakshi as HR headPeople Matters•Aug 30, 2024•Orient Electric, Panacea Biotec
•
Panacea Biotec gets Rs 5.75 crore demand from GST authority in MumbaiNewsDrum•Aug 20, 2024•Panacea Biotec
•
Panacea Biotec Q1 results : loss at ₹15.8Cr, Revenue decreased by 10.43% YoYMint•Aug 16, 2024•Panacea Biotec
•
ICMR, Panacea Biotec initiate first dengue vaccine Phase 3 Clinical Trial in IndiaIndiaMedToday•Aug 16, 2024•Panacea Biotec, ICMR
Are you a Founder ?
FAQs about Panacea Biotec
Explore our recently published companies
- Homeschool Facts - Unfunded company
- Canbas Bio - Tangerang based, 2018 founded, Unfunded company
- BioNordika - Finland based, 1995 founded, Public company
- Shangkentech.com - 2018 founded, Unfunded company
- Innovsense.com - 2022 founded, Unfunded company
- Jupho - Mumbai based, Unfunded company
